Position in GILD
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,070,731
-$22,347 QoQ
Shares Held
8,475
+8.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,041
of 2,266 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sovran Advisors, LLC holds $15,425,682 across 12 Drug Manufacturers - General names. GILD ranks #5 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,612 | $4,332,340 | |
| 2 | JNJ |
Johnson & Johnson
|
12,511 | $3,177,418 | |
| 3 | ABBV |
AbbVie Inc.
|
7,668 | $1,929,575 | |
| 4 | AMGN |
Amgen Inc
|
3,667 | $1,327,894 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
8,475 | $1,070,731 | |
| 6 | NVS |
Novartis AG
|
4,829 | $756,800 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
10,409 | $599,766 | |
| 8 | PFE |
Pfizer Inc
|
23,935 | $576,354 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,070,731 | 8,475 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,093,078 | 7,843 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $825,794 | 6,728 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $654,678 | 5,898 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $703,470 | 6,345 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $766,197 | 6,838 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $513,577 | 5,560 | Shares | Sole | 2025-01-29 | |
| No filing history on record for this holder in this stock. | ||||||